OBJECTIVE: To systematically evaluate the immune function in patients with colorectal cancer after laparoscopic surgery (LS) and conventional open surgery (OS). METHODS: PUBMED, EMBASE, and the Cochrane library were searched and randomized controlled trials (RCTs) comparing the immunological difference between LS and OS were included. Two authors extracted data and assessed trial quality. RESULTS: Eleven studies including 695 patients were analysed. Immune-competent cells demonstrated no significant differences between LS and OS in six trials. Eight trials assessed various perioperative plasma cytokine concentrations with no significant differences in interleukin-6 (IL-6) and C-reactive protein (CRP) levels between LS and OS. However, meta-analysis showed higher T suppressor lymphocytes (CD8+) counts on postoperative days (POD) 1-3 and lower plasma levels of CRP on POD 0-1 in LS group compared with OS group. CONCLUSION: Although LS groups displayed higher T suppressor lymphocyte (CD8+) counts on postoperative days (POD) 1-3 and lower plasma levels of CRP on POD 0-1, there is no sufficient evidence to support superior preservation of global immune function with LS compared to OS.
OBJECTIVE: To systematically evaluate the immune function in patients with colorectal cancer after laparoscopic surgery (LS) and conventional open surgery (OS). METHODS: PUBMED, EMBASE, and the Cochrane library were searched and randomized controlled trials (RCTs) comparing the immunological difference between LS and OS were included. Two authors extracted data and assessed trial quality. RESULTS: Eleven studies including 695 patients were analysed. Immune-competent cells demonstrated no significant differences between LS and OS in six trials. Eight trials assessed various perioperative plasma cytokine concentrations with no significant differences in interleukin-6 (IL-6) and C-reactive protein (CRP) levels between LS and OS. However, meta-analysis showed higher T suppressor lymphocytes (CD8+) counts on postoperative days (POD) 1-3 and lower plasma levels of CRP on POD 0-1 in LS group compared with OS group. CONCLUSION: Although LS groups displayed higher T suppressor lymphocyte (CD8+) counts on postoperative days (POD) 1-3 and lower plasma levels of CRP on POD 0-1, there is no sufficient evidence to support superior preservation of global immune function with LS compared to OS.
Authors: C Sietses; M J Wiezer; Q A Eijsbouts; R H Beelen; P A van Leeuwen; B M von Blomberg; S Meijer; M A Cuesta Journal: Surgery Date: 1999-07 Impact factor: 3.982
Authors: Ethan M Balk; Peter A L Bonis; Harry Moskowitz; Christopher H Schmid; John P A Ioannidis; Chenchen Wang; Joseph Lau Journal: JAMA Date: 2002-06-12 Impact factor: 56.272
Authors: J G Stage; S Schulze; P Møller; H Overgaard; M Andersen; V B Rebsdorf-Pedersen; H J Nielsen Journal: Br J Surg Date: 1997-03 Impact factor: 6.939
Authors: R C Frazee; J W Roberts; R E Symmonds; S K Snyder; J C Hendricks; R W Smith; M D Custer; J B Harrison Journal: Ann Surg Date: 1994-06 Impact factor: 12.969
Authors: Marek Zawadzki; Malgorzata Krzystek-Korpacka; Andrzej Gamian; Wojciech Witkiewicz Journal: Int J Colorectal Dis Date: 2016-11-04 Impact factor: 2.571
Authors: O Bulut; K K Aslak; K Levic; C B Nielsen; E Rømer; S Sørensen; I J Christensen; H J Nielsen Journal: Tech Coloproctol Date: 2014-11-08 Impact factor: 3.781
Authors: Simran Grewal; Rianne Korthouwer; Marijn Bögels; Rens Braster; Niels Heemskerk; Andries E Budding; Stephan M Pouw; Jack van Horssen; Marjolein Ankersmit; Jeroen Meijerink; Petrousjka van den Tol; Steven Oosterling; Jaap Bonjer; Nuray Gül; Marjolein van Egmond Journal: Oncoimmunology Date: 2018-07-26 Impact factor: 8.110
Authors: Iwona Głowacka-Mrotek; Magdalena Tarkowska; Michał Jankowski; Tomasz Nowikiewicz; Zygmunt Siedlecki; Wojciech Hagner; Wojciech Zegarski Journal: Wideochir Inne Tech Maloinwazyjne Date: 2019-04-29 Impact factor: 1.195